Seven Eight Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-32,279
| Closed | -$663K | – | 421 |
|
|
2024
Q3 | $663K | Sell |
32,279
-24,134
| -43% | -$496K | 0.06% | 506 |
|
|
2024
Q2 | $1.26M | Buy |
+56,413
| New | +$1.26M | 0.13% | 270 |
|
|
2024
Q1 | – | Sell |
-61,192
| Closed | -$1.87M | – | 750 |
|
|
2023
Q4 | $1.87M | Buy |
61,192
+42,034
| +219% | +$1.28M | 0.22% | 137 |
|
|
2023
Q3 | $606K | Buy |
19,158
+7,549
| +65% | +$239K | 0.07% | 352 |
|
|
2023
Q2 | $473K | Buy |
+11,609
| New | +$473K | 0.08% | 323 |
|
|
2023
Q1 | – | Sell |
-13,464
| Closed | -$470K | – | 556 |
|
|
2022
Q4 | $470K | Buy |
+13,464
| New | +$470K | 0.12% | 234 |
|